Plaquenil (AvKARE, Inc.)
Welcome to the PulseAid listing for the Plaquenil drug offered from AvKARE, Inc.. This Antirheumatic Agent [EPC],Antimalarial [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | AvKARE, Inc. |
NON-PROPRIETARY NAME: | Hydroxychloroquine Sulfate |
SUBSTANCE NAME: | HYDROXYCHLOROQUINE SULFATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Antirheumatic Agent [EPC],Antimalarial [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2016-07-14 |
END MARKETING DATE: | 0000-00-00 |
Plaquenil HUMAN PRESCRIPTION DRUG Details:
Item Description | Plaquenil from AvKARE, Inc. |
LABELER NAME: | AvKARE, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 200(mg/1) |
START MARKETING DATE: | 2016-07-14 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 42291-335_5e9db729-f062-d2c6-490b-7aabd2091c56 |
PRODUCT NDC: | 42291-335 |
APPLICATION NUMBER: | NDA009768 |
Other HYDROXYCHLOROQUINE SULFATE Pharmaceutical Manufacturers / Labelers: